Effects of the D 3 preferring dopamine agonist pramipexole on sleep and waking, locomotor activity and striatal dopamine release in rats

By Lagos P.   Scorza C.   Monti J.M.   Jantos H.   Reyes-Parada M.   Silveira R.   Ponzoni A.  

European Neuropsychopharmacology, Vol. 8, Iss. 2, 1998-05 ,pp. : 113-120

Elsevier

Access to resources Recommend Favorite

Cotreatment with the kappa opioid agonist U69593 enhances locomotor sensitization to the D2/D3 dopamine agonist quinpirole and alters dopamine D2 receptor and prodynorphin mRNA expression in rats

By Perreault Melissa   Graham Dawn   Scattolon Sarah   Wang Yufang   Szechtman Henry   Foster Jane  

Psychopharmacology, Vol. 194, Iss. 4, 2007-11 ,pp. : 485-496

Springer Publishing Company

Access to resources Recommend Favorite

Electroencephalographic effects of a dopamine D 3 receptor agonist: a computerized study in rabbits

By Popoli P.   Pegrave zzola A.   Reggio R.   de Carolis A.S.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 407-407

Elsevier

Access to resources Recommend Favorite

Effects of D1 and D2 dopamine receptor antagonists on cocaine-induced self-stimulation and locomotor activity in rats

By Kita K.   Shiratani T.   Takenouchi K.   Fukuzako H.   Takigawa M.  

European Neuropsychopharmacology, Vol. 9, Iss. 1, 1999-01 ,pp. : 1-7

Elsevier

Access to resources Recommend Favorite

Stimulating dopamine D 1 receptors increases the locomotor activity of developing rats

By Guei-Jen S.   Walters D.E.  

European Journal of Pharmacology, Vol. 311, Iss. 2, 1996-09 ,pp. : 103-107

Elsevier

Access to resources Recommend Favorite